TANK (NT) Blocking Peptide

Pricing & Details

Product No.T300
Protein
TANK
Formats AvailableView All
Product Type
Blocking Peptide
Alternate Names
TRAF Family Member-Associated NF-kappaB Activator, I-TRAF
Applications
IHC FFPE
,
N
,
WB
Prod No.
Size
Price
Avail.
Qty
Add to cart
T300-50 µg
50 µg
$115.00
In stock
Max:
Min: 1
Step: 1

Antibody Details

Product Details

Reactivity Species
Human
Product Concentration
0.2 mg/ml
Amino Acid Location
14 amino acids near the amino terminus of human TANK.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Background
TANK peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

Antigen Details

Protein
PubMed

References & Citations

1. Krokan HE, Otterlei M, Nilsen H, et al. Properties and functions of human uracil-DNA glycosylase from the UNG gene. Prog. Nucleic Acid Res. Mol. Biol. 2001; 68:365-86. 2. Fromm JC and Verdine GL. Base excision repair. Adv. Protein Chem. 2004; 69:1-41. 3. Willetts KE, Rey F, Agostini I, et al. DNA repair enzyme uracil DNA glycosylase is specifically incorporated into human immunodeficiency virus type 1 viral particles through a Vpr-independent mechanism. J. Virol. 1999; 73:1682-8. 4. Harris RS, Bishop KN, Sheehy AM, et al. DNA deamination mediates innate immunity to retroviral infection. Cell 2003; 113:803-9
IHC
General Western Blot Protocol
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Cookie Policy
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy.